lung cancer
Conditions
Interventions
Case series:Case series
Sponsors
the First Affiliated Hospital of Soochow University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Patients with clinically confirmed lung cancer and pathological examination of adenocarcinoma, and have signed informed consent; 2. Between the ages of 18 and 75 years; 3. Infection, acidosis, electrolyte disorders, hypertension, etc. are effectively controlled.
Exclusion criteria
Exclusion criteria: 1. Patients with squamous cell carcinoma, large cell carcinoma and small cell lung cancer were clinically and pathologically detected; 2. Patients with severe primary diseases of the heart, brain, liver and hematopoietic system, who could not tolerate surgery; 3. most of the diagnosis clear stage IV and most IIIb, and part of IIIa stage non-small cell lung cancer, and staging later than T1-2N0-1M0 stage small cell lung cancer; 4. Women who are pregnant or breastfeeding.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| epidermal growth factor receptor;M2 pyruvate kinase;inhibitor of apoptosis proteins;gastrin precursors release peptide fragments;next generation sequencing; | — |
Countries
China
Contacts
Public ContactMinggang Wei
the First Affiliated Hospital of Soochow University
Outcome results
None listed